Index S&P 500
P/E 26.88
EPS (ttm) 3.70
Insider Own 0.08%
Shs Outstand 1.28B
Perf Week -3.31%
Market Cap 127.55B
Forward P/E 16.24
EPS next Y 6.13
Insider Trans -3.17%
Shs Float 1.28B
Perf Month 0.76%
Enterprise Value 148.52B
PEG 2.65
EPS next Q 1.34
Inst Own 87.40%
Short Float 1.54%
Perf Quarter 3.84%
Income 4.76B
P/S 3.67
EPS this Y 2.90%
Inst Trans 0.75%
Short Ratio 2.56
Perf Half Y 8.16%
Sales 34.76B
P/B 2.62
EPS next Y 8.44%
ROA 5.26%
Short Interest 19.72M
Perf YTD 3.57%
Book/sh 37.95
P/C 15.32
EPS next 5Y 6.14%
ROE 9.81%
52W High 106.33 -6.43%
Perf Year 7.91%
Cash/sh 6.50
P/FCF 24.50
EPS past 3/5Y -1.03% 0.39%
ROIC 6.24%
52W Low 79.55 25.07%
Perf 3Y 17.89%
Dividend Est. 2.85 (2.87%)
EV/EBITDA 15.66
Sales past 3/5Y 1.91% 3.01%
Gross Margin 59.95%
Volatility 2.38% 2.18%
Perf 5Y -16.91%
Dividend TTM 2.83 (2.84%)
EV/Sales 4.27
EPS Y/Y TTM 13.15%
Oper. Margin 18.61%
ATR (14) 2.18
Perf 10Y 35.54%
Dividend Ex-Date Dec 26, 2025
Quick Ratio 1.80
Sales Y/Y TTM 5.34%
Profit Margin 13.71%
RSI (14) 44.58
Recom 1.91
Dividend Gr. 3/5Y 3.57% 5.33%
Current Ratio 2.42
EPS Q/Q 8.10%
SMA20 -1.60%
Beta 0.72
Target Price 112.42
Payout 77.47%
Debt/Eq 0.60
Sales Q/Q 6.64%
SMA50 -0.09%
Rel Volume 1.35
Prev Close 100.88
Employees 95000
LT Debt/Eq 0.57
Earnings Feb 17 BMO
SMA200 6.53%
Avg Volume 7.69M
Price 99.49
IPO Nov 21, 1977
Option/Short Yes / Yes
EPS/Sales Surpr. 3.49% 1.06%
Trades
Volume 10,353,496
Change -1.38%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-13-26 Resumed
Barclays
Overweight
$116
Feb-09-26 Upgrade
Needham
Hold → Buy
$121
Feb-03-26 Resumed
Citigroup
Buy
$117
Jan-30-26 Resumed
Wells Fargo
Overweight
$114
Jan-06-26 Upgrade
William Blair
Mkt Perform → Outperform
Nov-19-25 Upgrade
Goldman
Sell → Neutral
$111
Jun-30-25 Upgrade
Wolfe Research
Underperform → Peer Perform
Jun-16-25 Initiated
Leerink Partners
Outperform
$110
Mar-04-25 Upgrade
Citigroup
Neutral → Buy
$92 → $107
Oct-10-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$98 → $105
Aug-21-24 Reiterated
Oppenheimer
Perform
$92 → $94
Aug-15-24 Upgrade
UBS
Sell → Neutral
$76 → $90
Aug-14-24 Downgrade
Stifel
Buy → Hold
$100 → $85
May-30-24 Initiated
Goldman
Sell
$83
Jul-19-23 Initiated
Robert W. Baird
Neutral
$90
Jun-30-23 Initiated
CL King
Buy
$106
May-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$104
Apr-24-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$77 → $100
Mar-29-23 Downgrade
UBS
Buy → Sell
$127 → $79
Jan-09-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$102 → $89
Show Previous Ratings
Feb-13-26 07:00PM
03:30PM
(The Wall Street Journal)
11:04AM
09:49AM
08:38AM
08:01AM
Loading…
08:01AM
Here Are Fridays Top Wall Street Analyst Research Calls: Airbnb, AMD, Broadcom, CrowdStrike, Dollar Tree, Medtronic, Pinterest, Rivian, Roku, Tapestry, and More
(24/7 Wall St.)
08:00AM
Feb-11-26 01:56PM
11:14AM
09:15AM
Feb-09-26 05:45PM
10:54AM
09:36AM
08:02AM
07:43AM
01:14PM
Loading…
Feb-06-26 01:14PM
Feb-05-26 02:21PM
Feb-04-26 06:42AM
Feb-03-26 05:55PM
12:21PM
11:18AM
08:17AM
08:00AM
06:11AM
Feb-02-26 11:08AM
09:17AM
Jan-30-26 05:50PM
05:10PM
02:31PM
09:54AM
07:59AM
Loading…
07:59AM
Jan-27-26 02:13PM
05:23AM
05:00AM
Jan-26-26 05:54PM
(The Wall Street Journal)
05:39AM
Jan-24-26 09:01AM
Jan-23-26 01:57PM
11:07AM
07:59AM
07:02AM
Jan-22-26 05:50PM
10:03AM
05:41AM
Jan-21-26 07:07PM
(Investor's Business Daily)
12:30PM
07:59AM
05:50AM
Jan-18-26 04:35PM
Jan-16-26 12:45PM
07:18AM
Jan-15-26 09:36AM
08:42AM
05:00AM
Jan-14-26 10:13AM
Jan-13-26 02:07PM
01:40PM
01:02PM
12:19PM
07:48AM
Jan-12-26 09:00AM
07:45AM
Jan-09-26 01:24PM
09:50AM
09:16AM
08:16AM
Jan-08-26 11:40AM
Jan-07-26 09:05AM
08:41AM
Jan-06-26 09:38AM
04:40AM
Jan-05-26 04:43PM
07:41AM
Jan-03-26 02:00PM
Jan-02-26 07:00PM
07:20AM
Dec-31-25 04:31PM
01:07PM
07:21AM
Dec-30-25 12:27PM
09:35AM
Dec-29-25 07:20PM
10:03AM
Dec-28-25 03:00AM
Dec-27-25 05:20AM
Dec-24-25 07:17PM
05:46PM
Dec-23-25 10:21AM
07:42AM
07:20AM
Dec-22-25 11:40AM
11:07AM
09:53AM
08:03AM
(The Wall Street Journal)
01:50AM
Dec-20-25 01:35PM
Dec-19-25 05:02PM
04:53PM
(The Wall Street Journal)
04:47PM
04:20PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smith Gregory L EVP Global Ops & Supply Chain Nov 19 '25 Sale 101.95 30,000 3,058,451 46,016 Nov 21 04:13 PM Smith Gregory L Officer Nov 19 '25 Proposed Sale 101.95 30,000 3,058,452 Nov 19 11:05 AM KIIL HARRY SKIP EVP & President Cardiovascular Sep 03 '25 Sale 91.58 8,605 788,048 35,615 Sep 05 04:18 PM KIIL HARRY SKIP Officer Sep 03 '25 Proposed Sale 91.58 8,605 788,049 Sep 03 03:23 PM Jellison William R Director Aug 22 '25 Buy 92.73 2,500 231,825 2,500 Aug 25 05:18 PM Jellison William R Director Aug 25 '25 Buy 92.37 2,500 230,925 5,000 Aug 25 05:18 PM Walter Matthew R. SVP, Chief HR Officer Aug 01 '25 Option Exercise 23.91 3,142 75,114 32,804 Aug 04 04:21 PM Wall Brett A. EVP & Pres Neuroscience Aug 01 '25 Option Exercise 0.00 15,249 0 66,531 Aug 04 04:20 PM Smith Gregory L EVP Global Ops & Supply Chain Aug 01 '25 Option Exercise 0.00 11,328 0 83,071 Aug 04 04:19 PM Martha Geoffrey Chairman and CEO Aug 01 '25 Option Exercise 32.21 98,324 3,166,800 284,923 Aug 04 04:18 PM Marinaro Michael EVP, Pres MedSurg and Americas Aug 01 '25 Option Exercise 25.24 9,661 243,828 57,628 Aug 04 04:17 PM KIIL HARRY SKIP EVP & President Cardiovascular Aug 01 '25 Option Exercise 0.00 10,457 0 51,775 Aug 04 04:16 PM Blomquist Denise L. Chief Accounting Officer Aug 01 '25 Option Exercise 32.22 518 16,692 12,671 Aug 04 04:15 PM Salmon Sean Officer Jun 06 '25 Proposed Sale 86.81 18,378 1,595,469 Jun 06 02:43 PM